Meeting the Challenges of the Moment
When conducting clinical studies, expectations can be elevated, resources limited and timelines challenging. When your objective is to accomplish the impossible, who can you turn to for the flexibility and know-how you need to go the distance wherever you are in your clinical journey?
Veristat can advance your therapy from any point and keep your milestones on track. This month, we are highlighting some of the ways we put our scientific expertise and flexible approaches to work and help sponsors advance their therapies into and through clinical development.
Webinar: Expediting Access to Novel/Medicinal Products in the US and EU | Regulatory Pathways to Speed Development and Approval
Date: 26 April, 2022 | Time: UTC (London) 15:00 / (UTC+1/ Spain) 16:00 pm / 10:00 am EST
In collaboration with TOPRA, Veristat Regulatory experts uncover how drug developers can use some or multiple programs/pathways to accelerate approval in the US and Europe. The webinar highlights the requirements, benefits, and procedures for following US pathways and examines the similarities and differences between US and EU pathways. Real-world examples showcase the essentials needed to support study success.
Newest Solution: Strategic Resourcing Now Available to You
Ever wonder who you can turn to for those hard-to-find scientific resources that can seamlessly integrate into your in-house processes? Look no further. Our Strategic Resourcing solution provides the delivery of clinical research and regulatory expertise tailored to your needs. Now, specify services and resources delivered at the ideal time and managed in a flexible manner to avoid project delays, missed milestones, or deliverable failures.
Recommended by LinkedIn
Case Study: Running Successful Clinical Programs with an External Biostatistics Team
A biotechnology company start-up specializing in rare disease research began working with Veristat a decade ago. Our initial engagement started with strategic statistical consulting by our Chief Statistician to help analyze data from a natural history study. The relationship grew with the inclusion of our biostatistics team and many other functional groups to support the company’s fast-track growth from a four to a 300+ person team. Today, our relationship remains strong and successful.
Mark Your Calendars!
Webinar: Expediting Access to Novel/Medicinal Products in the US and EU | Regulatory Pathways to Speed Development and Approval. 26 April 2022.
Director, Business Development ICON, plc
2yMark your calendars!